This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Thermo Fisher Scientific is a scientific instrument maker and a world leader in serving science. In Nov 2006, Thermo Fisher Scientific, Inc. was formed through the merger of Thermo Electron Corporation with Fisher Scientific International Inc. On Feb 3, 2014, Thermo Fisher acquired Life Technologies Corporation. Following the acquisition, the new reporting segments are: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.
Top Analyst Reports for Microsoft, Broadcom & McDonald's
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Microsoft Corporation (MSFT), Broadcom Inc. (AVGO) and McDonald's Corporation (MCD), as well as a micro-cap stock Kingsway Financial Services Inc. (KFS).
Centene Q1 Earnings Beat Estimates on Marketplace Business Strength
by Zacks Equity Research
CNC's Q1 results benefit from improved premiums as a result of a strong PDP business, partly offset by elevated operating costs. It currently expects 2025 premium and service revenues within $164-$166 billion.
Thermo Fisher's Q1 Earnings Top Estimates, Revenues Beat, Stock Up
by Zacks Equity Research
TMO continues to advance its growth strategy and trusted partner status with customers in the first quarter of 2025.
Thermo Fisher (TMO) Reports Q1 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
While the top- and bottom-line numbers for Thermo Fisher (TMO) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Thermo Fisher Scientific (TMO) Q1 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Thermo Fisher (TMO) delivered earnings and revenue surprises of 0.98% and 1.11%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
ISRG Q1 Earnings Coming Up: Time to Buy, Sell or Hold the Stock?
by Zacks Equity Research
Intuitive Surgical's first-quarter results are likely to reflect solid performance in the company???s Instruments & Accessories segment. Improving margins buoy optimism.
Stay Ahead of the Game With Thermo Fisher (TMO) Q1 Earnings: Wall Street's Insights on Key Metrics
by Zacks Equity Research
Get a deeper insight into the potential performance of Thermo Fisher (TMO) for the quarter ended March 2025 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
Analysts Estimate Thermo Fisher Scientific (TMO) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Thermo Fisher (TMO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Robust Specialty Diagnostics Segment Likely to Aid TMO's Q1 Earnings
by Zacks Equity Research
Strength in Analytical Instruments and Specialty Diagnostics segments is likely to have driven Thermo Fisher's first-quarter 2025 performance.
The Zacks Analyst Blog Highlights Eli Lilly, American Express, Thermo Fisher, Steel Partners and Oil-Dri
by Zacks Equity Research
Eli Lilly, American Express, Thermo Fisher, Steel Partners and Oil-Dri are included in this Analyst Blog.
Top Research Reports for Eli Lilly, American Express & Thermo Fisher
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly and Company (LLY), American Express Company (AXP) and Thermo Fisher Scientific Inc. (TMO), as well as two micro-cap stocks, Steel Partners Holdings L.P. (SPLP) and Oil-Dri Corporation of America (ODC).
Thermo Fisher (TMO) Surges 8.2%: Is This an Indication of Further Gains?
by Zacks Equity Research
Thermo Fisher (TMO) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Thermo Fisher Stock Benefits From the Launch of Krios 5 Cryo-TEM
by Zacks Equity Research
TMO launches the Krios 5 Cryo-TEM, boosting productivity and performance with enhanced automation.
Is it Worth Retaining Thermo Fisher Stock in Your Portfolio Now?
by Zacks Equity Research
TMO continues to hold on to investors' attention due to its value-added acquisitions and trusted end-market channels.
Bio-Techne Opens New Customer Experience Centre in Germany
by Zacks Equity Research
TECH announces the opening of a new Customer Experience Centre to support long-term growth in the EMEA region. The new facility is located in Dusseldorf, Germany.
Charles River & Valo Health's Logica Identifies New Lupus Drug Candidate
by Zacks Equity Research
Charles River and Valo Health identify a potential therapeutic for lupus using their combined offering, Logica.
Thermo Fisher's New Deal With CZ Imaging Institute May Boost Its Stock
by Zacks Equity Research
TMO and CZ Imaging Institute to collaborate on further understanding of human cells.
TMO Stock Set to Gain From the Launch of New Vulcan Automated Lab
by Zacks Equity Research
Thermo Fisher introduces the Vulcan Automated Lab to transform semiconductor analysis.
The Zacks Analyst Blog Highlights Visa, Johnson & Johnson, Thermo Fisher and AMREP
by Zacks Equity Research
Visa, Johnson & Johnson, Thermo Fisher and AMREP are included in this Analyst Blog.
Top Stock Reports for Visa, Johnson & Johnson & Thermo Fisher Scientific
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Visa Inc. (V), Johnson & Johnson (JNJ) and Thermo Fisher Scientific Inc. (TMO), as well as a micro-cap stock AMREP Corporation (AXR).
The Zacks Analyst Blog Highlights Broadcom, Thermo Fisher Scientific, Aon and Massimo
by Zacks Equity Research
Broadcom, Thermo Fisher Scientific, Aon and Massimo are included in this Analyst Blog.
Top Stock Reports for Broadcom, Thermo Fisher & Aon
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Broadcom Inc. (AVGO), Thermo Fisher Scientific Inc. (TMO) and Aon plc (AON), as well as a micro-cap stock, Massimo Group (MAMO).
TMO Stock Set to Gain From The Launch of New Spatial Imaging System
by Zacks Equity Research
Thermo Fisher's Invitrogen EVOS S1000 Spatial Imaging System addresses the limitations of current fluorescent microscopy technologies.
Thermo Fisher Q4 Earnings and Revenues Top Estimates, Stock Up
by Zacks Equity Research
In the fourth quarter of 2024, TMO continued to advance its growth strategy and trusted partner status with customers.
Thermo Fisher (TMO) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
While the top- and bottom-line numbers for Thermo Fisher (TMO) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.